This report investigates the green synthesis of gallium (Ga)-doped zinc oxide (ZnO) nanoparticles, utilizing Piper betle leaf extract as a plant-based reducing and stabilizing agent, along with various characterizations. Undoped ZnO and Ga-doped ZnO at concentrations of 0.5 %, 1 %, and 2 % (ZO, GZO 0.5 %, GZO 1 % and GZO 2 %) were fabricated applying a co-precipitation method. The successful substitution of Ga³ ⁺ ions within the ZnO lattice was confirmed through structural characterization via X-ray diffraction (XRD), showing the formation of the hexagonal wurtzite structure without any secondary phases. As the doping concentration increased, the XRD analysis indicated a reduction in crystallite size, while scanning electron microscopy (SEM) illustrated smaller grain sizes and enhanced homogeneity, which were attributed to the suppression of crystal growth. Using energy-dispersive X-ray spectroscopy (EDX), the elemental composition and successful incorporation of Ga were confirmed. The obtained bandgap of ZO is 3.95 eV, increases to 4.02 eV for GZO 0.5 %, and then slightly decreases to 3.99 eV and 3.96 eV for GZO 1 % and GZO 2 %, respectively. Antibacterial screening against Escherichia coli and Staphylococcus aureus bacterium confirmed that Ga-doped ZnO had larger inhibition zones, particularly at higher doses. The results demonstrate the feasibility of using Ga-doped ZnO nanoparticles made using environmentally friendly techniques for antimicrobial therapy and environmental cleanup, in accordance with the principles of green chemistry.
Shakib et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: